Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings

ESMO Virtual Plenary: February 2023

ESMO-Virtual-Plenary-February-2023-1000x250-AACR-date
Start date
16 Feb 2023
End date
17 Feb 2023
Location
Virtual Meeting

Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study

Thursday, 16 February 2023

Friday, 17 February 2023

18:30-19:30 CET

13:00-14:10 CET

Welcome and introduction, Scientific background and context
Florian Lordick, Leipzig University Medical Center, Leipzig, Germany

Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study
Sun Young Rha, Yonsei University, Seoul, Republic of Korea

Critical analysis and perspectives (ESMO)
Elizabeth Smyth, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

AACR expert commentary
Brian S. Henick, Columbia University Irving Medical Center / Herbert Irving Comprehensive Cancer Center, New York, NY, USA

Discussion and Q&A (i)
Faculty and online audience

Virtual Plenary Expert Insights: Webcast of 16 February presentations, Discussion and Q&A (ii)
Faculty and online audience

Chair: Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan

Sun Young Rha, Yonsei University, Seoul, Republic of Korea

Elizabeth Smyth, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

Matthew Chau Hsien Ng, National Cancer Centre Singapore, Singapore

Li-Tzong Chen, National Health Research Institutes, Tainan City, Taiwan  

Meeting resources

Slides and webcasts from ESMO Virtual Plenaries are open to all ESMO Account holders, according to the presenters' agreement to release them.

Login and Watch now!

See all resources

You may also be interested in...

ESMO Virtual Plenaries

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.